Pharmasset (VRUS +4%) shares are on the move after favorable analyst notes: Piper Jaffray...

|By:, SA News Editor

Pharmasset (VRUS +4%) shares are on the move after favorable analyst notes: Piper Jaffray initiates coverage at Overweight, and Brean Murray raises its price target to $105 from $87. On top of that, Briefing.com reports hearing that a firm has issued positive comments regarding the company's potential valuation in an M&A scenario.